Guerbet
Quick facts
Marketed products
- DOTAREM · Diagnostic Imaging
DOTAREM is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the relaxation time of water protons in tissues. - Dotarem®-enhanced MRI · Diagnostic Imaging
Dotarem is a gadolinium-based contrast agent that enhances MRI signal by altering the magnetic properties of nearby water molecules in tissues. - Elucirem · Other
- Dotarem · Other
Gadoterate enhances MRI image brightness by shortening T1 and T2 relaxation times in tissues. - Gadovist®/Gadavist® · Diagnostic Imaging
Gadovist is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the relaxation time of water protons in tissues. - Iodixanol 320 mgI/mL · Diagnostic Imaging
Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and body cavities by absorbing X-rays. - Ioversol 320 mgI/mL · Diagnostic Imaging
Ioversol is a non-ionic, iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures. - Ioxitol · Other
- Lipiodol Ultra Fluid with surgical glues · Surgery / Interventional Radiology
Lipiodol Ultra Fluid is an iodized poppy seed oil contrast agent that provides radiographic visualization and can be combined with surgical adhesives for hemostasis and tissue sealing during surgical procedures. - Xenetix · Other
- Xenetix-CT perfusion imaging · Diagnostic Imaging
Xenetix is an iodinated contrast medium that enhances visualization of blood perfusion in tissues during CT imaging by increasing radiodensity in vascular and tissue compartments.
Phase 3 pipeline
- Dotarem (gadoterate meglumine) · Diagnostic Imaging
Gadoterate meglumine is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the T1 relaxation time of water protons in tissues. - Gadoterate meglumine (Dotarem) · Diagnostic Imaging
Gadoterate meglumine is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the relaxation time of water protons in tissues.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: